6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+14.38%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$999M
AUM Growth
+$999M
(+1.2%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-11.92%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
273
New
130
Increased
21
Reduced
37
Closed
21
Top Buys
| 1 |
BorgWarner
BWA
|
$20.7M |
| 2 |
Hilton Grand Vacations
HGV
|
$20.4M |
| 3 |
Carvana
CVNA
|
$17.7M |
| 4 |
NCR Atleos
NATL
|
$9.96M |
| 5 |
Sarepta Therapeutics
SRPT
|
$6.42M |
Top Sells
| 1 |
Enova International
ENVA
|
$34.3M |
| 2 |
FLG
Flagstar Financial, Inc.
FLG
|
$25.1M |
| 3 |
Vistra
VST
|
$20.2M |
| 4 |
Noble Corp
NE
|
$16.6M |
| 5 |
Phinia Inc
PHIN
|
$9.84M |
Sector Composition
| 1 | Healthcare | 28.47% |
| 2 | Consumer Discretionary | 22.93% |
| 3 | Financials | 12.63% |
| 4 | Materials | 5.87% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WHWK
76
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $404K | 0.03% |
+200,000
| New | +$404K |
|
77
Esperion Therapeutics
ESPR
$490M
| $403K | 0.03% |
+134,689
| New | +$403K |
|
|
SLRN
78
DELISTED
ACELYRIN
SLRN
| $400K | 0.03% |
+53,630
| New | +$400K |
|
79
The Honest Company
HNST
$441M
| $391K | 0.03% |
+118,494
| New | +$391K |
|
|
ML
80
DELISTED
MoneyLion Inc.
ML
| $367K | 0.03% |
+5,860
| New | +$367K |
|
81
Porch Group
PRCH
$1.86B
| $367K | 0.03% |
+119,034
| New | +$367K |
|
82
Lyra Therapeutics
LYRA
$11.8M
| $366K | 0.03% |
+1,397
| New | +$366K |
|
|
PLL
83
DELISTED
Piedmont Lithium
PLL
| $353K | 0.03% |
+12,500
| New | +$353K |
|
84
Tourmaline Bio
TRML
$645M
| $350K | 0.03% |
+13,356
| New | +$350K |
|
|
OMGA
85
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $346K | 0.03% |
115,000
-393,242
| -77% | -$1.18M |
|
|
ILPT
86
Industrial Logistics Properties Trust
ILPT
$389M
| $342K | 0.03% |
+72,798
| New | +$342K |
|
87
Applied Therapeutics
APLT
$73.7M
| $338K | 0.03% |
+100,806
| New | +$338K |
|
88
Sera Prognostics
SERA
$129M
| $336K | 0.03% |
+56,169
| New | +$336K |
|
89
Absci
ABSI
$356M
| $335K | 0.03% |
+79,780
| New | +$335K |
|
|
MTA
90
Metalla Royalty & Streaming
MTA
$516M
| $333K | 0.03% |
+109,080
| New | +$333K |
|
91
Mama's Creations
MAMA
$351M
| $329K | 0.03% |
+67,081
| New | +$329K |
|
92
Applied Optoelectronics
AAOI
$1.44B
| $317K | 0.03% |
+16,407
| New | +$317K |
|
93
Fulcrum Therapeutics
FULC
$353M
| $316K | 0.03% |
+46,778
| New | +$316K |
|
94
Ouster
OUST
$1.59B
| $315K | 0.03% |
+41,121
| New | +$315K |
|
95
C4 Therapeutics
CCCC
$182M
| $314K | 0.03% |
+55,602
| New | +$314K |
|
96
Acumen Pharmaceuticals
ABOS
$82.4M
| $301K | 0.02% |
+78,431
| New | +$301K |
|
97
Bioventus
BVS
$471M
| $297K | 0.02% |
+56,389
| New | +$297K |
|
98
Shattuck Labs
STTK
$61.3M
| $297K | 0.02% |
+41,638
| New | +$297K |
|
99
Ventyx Biosciences
VTYX
$184M
| $296K | 0.02% |
+120,000
| New | +$296K |
|
100
Virco
VIRC
$134M
| $296K | 0.02% |
+24,599
| New | +$296K |
|